Rugby league faces a dangerous financial crunch due to the coronavirus shutdown, but players, clubs and the NRL are working together to ensure the game's future.

Star netballer Natalie Medhurst was hoping to put her feet up this season as she prepares for the birth of her baby — but now she is helping lead her sport's response to the coronavirus.

It would be a short-sighted and costly move for Australia's sporting bodies to abandon women's leagues to help them cope with the financial fallout caused by coronavirus, writes Richard Hinds.

Professional tennis is on hold because of the coronavirus pandemic, but that does not stop 20-time major singles champion Roger Federer reaching out to his legion of fans with a bit of friendly advice on how to improve their game while stuck at home.

With stay-at-home restrictions in place across Australia, online gaming is set to take a big step towards mainstream adoption.

As pools, gyms and sports facilities shut down to comply with physical-distancing rules, Olympic and Paralympic athletes are coming up with creative ways to ensure their training programs can continue.

Cycling's most famous event may still go ahead this year, despite the French Government banning mass gatherings in the country until at least the middle of July.

It's usually a glamorous event in front of a packed arena, but this year's NFL draft will be broadcast from nearly 200 locations to sports-starved fans.

With uncertainty surrounding the men's T20 World Cup and Indian tour, former players have expressed interest in revisiting one of cricket's most famous experiments — Australia v Australia A.

Queensland is the first state to sign off on the planned May 28 return of the NRL and the Prime Minister hopes Border Force will allow the NZ Warriors into Australia shortly.

The livewire forward feels guilty about how AFL great Adam Goodes was driven out of the game, which is why he wants young Indigenous Australian players to call out racism.

Pop star Selena Gomez will executive produce and star in a quarantine cooking show on HBO Max, alongside master chefs who will join remotely.

Connections allows users to post spare plane tickets and the name of the person the ticket is registered to in hopes of finding a traveler with the same name.

A stowaway cat shocked small-plane pilot and passenger.

Georgia lifts many coronavirus-related restrictions, allowing gyms, hair salons, tattoo parlors and bowling alleys to reopen Friday.

Waterstones CEO: How I keep selling books while my bookshops are shut down.

Former NBA player Cliff Alexander -- the top H.S. recruit in the country in 2014 -- was arrested Wednesday ... after cops say they found a loaded gun on him during a traffic stop. TMZ Sports has learned ... Cliff was pulled over at around 9:30 PM…

Gregg Sulkin is not letting something like coronavirus torpedo his perfectly-toned physique. Gregg took in a workout Friday at an L.A. park, and he's clearly figured out a way to stay jacked during self-quarantine. He worked out for about an hour,…

The Coronation Street star is a volunteer during the coronavirus crisis

The Troublemaker singer has spoken out after pranking his girlfriend on TikTok during lockdown

By Suzan Onel and Vanessa Fulton On March 19, 2020, FDA issued a guidance document communicating its policy regarding postmarket adverse event reporting during a pandemic (“Guidance”).  The Guidance provides recommendations that affect adverse event reporting obligations for drugs, biologics, medical devices, combination products, and dietary supplements. To summarize, FDA states in the Guidance that

The post FDA Waives Certain Adverse Event Reporting Deadlines Across Product Industries During Pandemics appeared first on Kleinfeld Kaplan & Becker LLP.

By: Suzan Onel FDA issued a Press Release on March 28, 2020, reiterating what we all have seen in the news, there is a severe shortage of personal protective equipment (PPE) in health care facilities across the country.  In response to the shortages, FDA has issued Emergency Use Authorizations (EUAs) for respirators, ventilators, ventilator tubing

The post Shortage of PPE and other Devices During COVID-19 Pandemic – Is 3D Printing the Answer? appeared first on Kleinfeld Kaplan & Becker LLP.

LifeSignals, based in Fremont, California, announced that it received the CE Mark for its LifeSignals ECG Remote Monitoring Patch. The patch, integrated with a remote monitoring platform, is designed as a continuous electrocardiography (ECG) and heart rate monitor. The ECG Remote Monitoring Patch is disposable and captures data for up to three days. The device […]

VitalConnect announced that it has received FDA Emergency Use Authorization status for use of its VitalPatch to detect changes in the QT interval of hospitalized patients undergoing drug treatment for COVID-19. Hydroxychloroquine and chloroquine, used to treat some COVID-19 patients, are associated with risk of prolonged QT interval that can lead to life-threatening arrhythmias. VitalPatch allows […]

Since early February, custom material solutions provider, Compounding Solutions, has been working hard to meet material demands related to Covid-19.

Polyfuze Graphics, a global manufacturer of polymer fusion technology products for safety labelling and graphics, has introduced an antimicrobial safety product to help with Healthcare Associated Infections (HAIs) during the Covid-19 pandemic.

John Dogru, CEO of 3DPrinterOS, spoke to MPN’s editor Laura Hughes about the pivotal role of 3D printing during the Covid-19 pandemic.

Experts discuss recent cancellation of first-in-class drug

Get the inside information on what industry does and does NOT want from their academic counterparts: Join us June 16, 3-4 p.m. EDT for Insider’s Guide to Effective Partnering at BIO 2011, a FREE AUTM webinar to help you prepare for the BIO convention in Washington, DC, June 27-30.

RBX2660 may bring an innovative therapeutic option to patients suffering from C. diff

The Energy and Commerce Committee today announced a Health Subcommittee Hearing for Thursday, May 14, entitled “Protecting Scientific Integrity in the COVID-19 Response.”  The hearing notice follows this note to the media.   NOTE TO THE MEDIA: Due to COVID-19, the Committee will make every effort to adhere to the safety recommendations from the Centers for Disease Control and Prevention (CDC) and the Attending Physician.  Therefore, media access will be limited.  Please contact your respective gallery for details.  As always, congressional press credentials will be required.   May 7, 2020   HEARING  NOTICE   TO:                      Members of the Subcommittee on Health FROM:                Anna G. Eshoo, Chairwoman SUBJECT:           Subcommittee Hearing on “Protecting Scientific Integrity in the COVID-19 Response” The Subcommittee on Health of the Committee on Energy and Commerce will hold a hearing on Thursday, May 14, 2020, at 10 a.m. in the John D. Dingell Room, 2123 of the Rayburn House Office Building.  The hearing is entitled, “Protecting Scientific Integrity in the COVID-19 Response.”  Witnesses will be by invitation only.  Among the witnesses invited to testify is Dr. Rick A. Bright, former Director of the Biomedical Advanced Research and Development Authority. The logistics of this hearing will be different due to the current circumstances of conducting a public hearing during the COVID-19 pandemic.  Members will be advised regarding specifics on hearing procedures and briefings as soon as they become finalized. If you have any questions, please contact Meghan Mullon with the Committee staff at (202) 225-2927. The U.S. House of Representatives Office Buildings and the U.S. Capitol Complex are currently closed to the public.  Official meetings of the Committee and its subcommittees are broadcast and available on the Committee’s website:  www.energycommerce.house.gov. ###

The Subcommittee on Health of the Committee on Energy and Commerce will hold a hearing on Thursday, May 14, 2020, at 10 a.m. in the John D. Dingell Room, 2123 of the Rayburn House Office Building. The hearing is entitled, “Protecting Scientific Integrity in the COVID-19 Response.”  

In addition to tracing the early history of the Missouri and New York suits, we explain how these lawsuits are being used as conduits for misinformation.

The post Lawsuits as Conduits for Misinformation During COVID-19 appeared first on Bill of Health.

This was the first time in a long time that I’ve renewed my nursing license with the thought that I might need it — that I might be needed.

The post Preparing to Go Back to the Bedside During COVID-19: A Nurse-Turned-Bioethicist Reflects appeared first on Bill of Health.

These policies restricting abortion are unlikely to conserve PPE, and more importantly, they mischaracterize the nature and importance of abortions.

The post The Harms of Abortion Restrictions During the COVID-19 Pandemic appeared first on Bill of Health.

The question must be: can we accommodate non-emergent/non-urgent care safely or not, and if yes, which care do we address first as we re-open?

The post When and How to Resume Non-Urgent Care During COVID-19 appeared first on Bill of Health.

The solutions enable continuous remote monitoring of body temperature and other vitals, either at home or in care centers, for clinical trials.

The companyâs SiteVault Free tool, designed to enable collaborating between sites and study monitors, now has a remote monitoring feature.

The research collaboration will seek to identify candidate biomarkers for a group of inflammatory conditions, using AI and other advanced technology.

That emotion is natural in a situation like this, but there are ways to mitigate it

-- Read more on ScientificAmerican.com

Following meetings with then-Commissioner Scott Gottlieb and senior leadership from the Center for Drug Evaluation and Research on the role of CROs and technology companies in designing and implementing risk-based monitoring (RBM) of clinical trials, ACRO this week submitted extensive comments on recent FDA Guidance.Increasing the use of innovative RBM technologies helps make clinical trials safer, more efficient and higher quality. ACRO’s comments offer unique insights into the recent expansion of RBM implementation and call for further increasing the use of these oversight technologies.

On July 17, 2019, under cooperative agreement with the FDA, the Duke-Margolis Center for Health Policy (Duke Margolis) held a public workshop. The event, titled Improving the Implementation of Risk-Based Monitoring Approaches of Clinical Investigations, aimed to identify opportunities to improve Risk Based Monitoring (RBM) implementation and solicit stakeholder input on the challenges, barriers, and enablers that impact the successful adoption of RBM.

Pharmacists will be allowed to give out medication to patients who have already been receiving it

Pharmacists are to be allowed to hand out a range of super-strength medicines, including the heroin substitute methadone, without prescription during the Covid-19 crisis, under emergency measures that official drug policy advisers have warned could trigger a spike in drug misuse.

The Advisory Council for Misuse of Drugs (ACMD), which makes recommendations to the government on the control of dangerous drugs, was asked by the home secretary to consider the risks of lifting restrictions on certain substances controlled under the Misuse of Drugs Act.

The FDA has released a safety communication reiterating the need for doctors to closely monitor COVID-19 patients who are treated with either hydroxychloroquine or chloroquine.

Click to view a price quote on AGN.